The role of the calcitonin receptor in protecting against induced hypercalcemia is mediated via its actions in osteoclasts to inhibit bone resorption

Bone

Volumn 48, Issue 2, 2011, Pages 354-361

  Turner, Andrew G ^a   Tjahyono, Francisca ^a   Chiu, W S Maria ^a   Skinner, Jarrod ^a   Sawyer, Rebecca ^b   Moore, Alison J ^b   Morris, Howard A ^b   Findlay, David M ^b,c   Zajac, Jeffrey D ^a   Davey, Rachel A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Bone; Calcitonin receptor; Hypercalcemia; Knockout

Indexed keywords

CALCITONIN RECEPTOR; CALCIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HYPERCALCEMIA; KIDNEY TUBULE ABSORPTION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION;

ANIMALS; BONE RESORPTION; CALCITRIOL; CALCIUM; FEMALE; GENOTYPE; HYPERCALCEMIA; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; OSTEOCLASTS; POLYMERASE CHAIN REACTION; RECEPTORS, CALCITONIN;

EID: 78650994715     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.09.013     Document Type: Article

References (24)

1. Carter P.H., Schipani E. The roles of parathyroid hormone and calcitonin in bone remodeling: prospects for novel therapeutics. Endocr Metab Immune Disord Drug Targets 2006, 6:59-76.
2. Chiu W.S., McManus J.F., Notini A.J., Cassady A.I., Zajac J.D., Davey R.A. Transgenic mice that express Cre recombinase in osteoclasts. Genesis 2004, 39:178-185.
3. Dacquin R., Davey R.A., Laplace C., Levasseur R., Morris H.A., Goldring S.R., et al. Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol 2004, 164:509-514.
4. Davey R.A., Hahn C.N., May B.K., Morris H.A. Osteoblast gene expression in rat long bones: effects of ovariectomy and dihydrotestosterone on mRNA levels. Calcif Tissue Int 2000, 67:75-79.
5. Davey R.A., Moore A.J., Chiu M.W., Notini A.J., Morris H.A., Zajac J.D. Effects of amylin deficiency on trabecular bone in young mice are sex-dependent. Calcif Tissue Int 2006, 78:398-403.
6. Davey R.A., Turner A.G., McManus J.F., Chiu W.S., Tjahyono F., Moore A.J., et al. Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice. J Bone Miner Res 2008, 23:1182-1193.
7. Fox J. Developments in parathyroid hormone and related peptides as bone-formation agents. Curr Opin Pharmacol 2002, 2:338-344.
8. Gooi JH, Pompolo S, Karsdal MA, Kulkarni NH, Kalajzic I, McAhren SH. Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes. Bone 46(6):1486-97.
9. Hirsch P.F., Munson P.L. Thyrocalcitonin. Physiol Rev 1969, 49:548-622.
10. Ikegame M., Ejiri S., Ozawa H. Calcitonin-induced change in serum calcium levels and its relationship to osteoclast morphology and number of calcitonin receptors. Bone 2004, 35:27-33.
11. Kovacs C.S., Kronenberg H.M. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 1997, 18:832-872.
12. Marshall D. Calcium and phosphate kinetics. Calcium, phosphate and magnesium metabolism 1976, 257-297. Churchhill Livingstone, Edinburgh. B. Nordin (Ed.).
13. Morony S., Capparelli C., Lee R., Shimamoto G., Boone T., Lacey D.L., et al. A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3. J Bone Miner Res 1999, 14:1478-1485.
14. Morris H.A., Porter S.J., Durbridge T.C., Moore R.J., Need A.G., Nordin B.E. Effects of oophorectomy on biochemical and bone variables in the rat. Bone Miner 1992, 18:133-142.
15. Notini A.J., McManus J.F., Moore A., Bouxsein M., Jimenez M., Chiu W.S., et al. Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice. J Bone Miner Res 2007, 22:347-356.
16. O'Loughlin P.D., Morris H.A. Oestrogen deficiency impairs intestinal calcium absorption in the rat. J Physiol 1998, 511(Pt 1):313-322.
17. Sexton P.M., Findlay D.M., Martin T.J. Calcitonin. Curr Med Chem 1999, 6:1067-1093.
18. Shinki T., Ueno Y., DeLuca H.F., Suda T. Calcitonin is a major regulator for the expression of renal 25-hydroxyvitamin D3-1alpha-hydroxylase gene in normocalcemic rats. Proc Natl Acad Sci U S A 1999, 96:8253-8258.
19. Sims N.A., Morris H.A., Moore R.J., Durbridge T.C. Increased bone resorption precedes increased bone formation in the ovariectomized rat. Calcif Tissue Int 1996, 59:121-127.
20. Singer F.R., Fredericks R.S., Minkin C. Salmon calcitonin therapy for Paget's disease of bone. The problem of acquired clinical resistance. Arthritis Rheum 1980, 23:1148-1154.
21. Wada S., Udagawa N., Nagata N., Martin T.J., Findlay D.M. Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts. Endocrinology 1996, 137:1042-1048.
22. Wallach S., Rousseau G., Martin L., Azria M. Effects of calcitonin on animal and in vitro models of skeletal metabolism. Bone 1999, 25:509-516.
23. Williams G.A., Hargis G.K., Galloway W.B., Henderson W.J. Evidence for thyrocalcitonin in man. Proc Soc Exp Biol Med 1966, 122:1273-1276.
24. Woodrow J.P., Sharpe C.J., Fudge N.J., Hoff A.O., Gagel R.F., Kovacs C.S. Calcitonin plays a critical role in regulating skeletal mineral metabolism during lactation. Endocrinology 2006, 147:4010-4021.